UMLT20123 / Van Veldhuizen / SMM & ProstateResearch Question:
Not to be listed on our site.
Basic Study Information
To explore the use of curcumin and piperine supplementation at a dose of 4 gram/5mg
twice a day in early stage prostate cancer patient undergoing active surveillance
or patients on observation for MGUS/ low-risk smoldering myeloma.
Lead Researcher (Principal Investigator)
Peter Van Veldhuizen
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search